New Zealand markets open in 5 hours 10 minutes

Biofrontera AG (B8FK.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
2.99500.0000 (0.00%)
At close: 05:36PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 18.20M
Enterprise value 15.95M
Trailing P/E 0.32
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.30
Price/book (mrq)1.05
Enterprise value/revenue 0.53
Enterprise value/EBITDA -6.98

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-83.22%
S&P500 52-week change 322.55%
52-week high 318.9000
52-week low 32.3500
50-day moving average 34.4867
200-day moving average 38.2020

Share statistics

Avg vol (3-month) 31.7k
Avg vol (10-day) 35.18k
Shares outstanding 56.08M
Implied shares outstanding 66.08M
Float 8646.39k
% held by insiders 130.17%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.047619:1
Last split date 314 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.32%
Operating margin (ttm)-43.74%

Management effectiveness

Return on assets (ttm)9.15%
Return on equity (ttm)2.33%

Income statement

Revenue (ttm)30.16M
Revenue per share (ttm)10.00
Quarterly revenue growth (yoy)-36.00%
Gross profit (ttm)N/A
EBITDA 4.24M
Net income avi to common (ttm)398k
Diluted EPS (ttm)9.4500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.64M
Total cash per share (mrq)0.54
Total debt (mrq)1.04M
Total debt/equity (mrq)6.00%
Current ratio (mrq)1.61
Book value per share (mrq)5.68

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A